Your browser doesn't support javascript.
loading
Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.
Mellors, Jack; Tipton, Tom; Fehling, Sarah Katharina; Akoi Bore, Joseph; Koundouno, Fara Raymond; Hall, Yper; Hudson, Jacob; Alexander, Frances; Longet, Stephanie; Taylor, Stephen; Gorringe, Andrew; Magassouba, N'Faly; Konde, Mandy Kader; Hiscox, Julian; Strecker, Thomas; Carroll, Miles.
  • Mellors J; Department of Research and Evaluation, United Kingdom (UK) Health Security Agency, Salisbury, United Kingdom.
  • Tipton T; Department of Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
  • Fehling SK; Wellcome Centre for Human Genetics and the Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Akoi Bore J; Wellcome Centre for Human Genetics and the Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Koundouno FR; Institute of Virology, Philipps University Marburg, Marburg, Germany.
  • Hall Y; Center for Training and Research on Priority Diseases including Malaria in Guinea, Conakry, Guinea.
  • Hudson J; Department of Research, Ministry of Health Guinea, Conakry, Guinea.
  • Alexander F; Department of Research, Ministry of Health Guinea, Conakry, Guinea.
  • Longet S; Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Taylor S; Department of Research and Evaluation, United Kingdom (UK) Health Security Agency, Salisbury, United Kingdom.
  • Gorringe A; Department of Research and Evaluation, United Kingdom (UK) Health Security Agency, Salisbury, United Kingdom.
  • Magassouba N; School of Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
  • Konde MK; Department of Biochemical Sciences, School of Biosciences and Medicine, University of Surrey, Surrey, United Kingdom.
  • Hiscox J; Department of Research and Evaluation, United Kingdom (UK) Health Security Agency, Salisbury, United Kingdom.
  • Strecker T; Wellcome Centre for Human Genetics and the Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Carroll M; Department of Research and Evaluation, United Kingdom (UK) Health Security Agency, Salisbury, United Kingdom.
Front Immunol ; 13: 857481, 2022.
Article en En | MEDLINE | ID: mdl-35493467
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Ebolavirus Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Ebolavirus Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article